diazepam has been researched along with maprotiline in 26 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (19.23) | 18.7374 |
1990's | 6 (23.08) | 18.2507 |
2000's | 9 (34.62) | 29.6817 |
2010's | 6 (23.08) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Anderson, J; Hutchinson, JT; Marks, P; Rees, HM; Vincent, R | 1 |
Belli, C; Corallo, S; Lucchelli, PE; Rossi, C; Selvini, A | 1 |
Kaltwasser, MT | 1 |
Budziszewska, B; Grochmal, A; Przegaliński, E | 1 |
Barkić, J; Filaković, P; Mandić, N | 1 |
Akane, A; Fukui, Y; Hama, K; Maseda, C; Matsubara, K; Tanabe, K | 1 |
Atri, PB; Julius, DA | 1 |
Liljequist, R; Linnoila, M; Mattila, MJ | 1 |
Abdelmalik, OM; Airaudo, CB; Gayte-Sorbier, A; Guerri, J; Tchiakpé, L; Verdier, M | 1 |
Airaudo, CB; Bianchi, C; Gayte-Sorbier, A; Verdier, M | 1 |
Bolognesi, R; Conti, M; Manca, C; Tsialtas, D; Vasini, P | 1 |
Kanba, S; Miyaoka, H; Nakaki, T; Shintani, F; Suzuki, E | 1 |
Ivkovic, N; Mladenovic, I; Petkoci, S; Stojic, D | 1 |
1 review(s) available for diazepam and maprotiline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for diazepam and maprotiline
Article | Year |
---|---|
Antidepressant treatment with maprotiline in the management of emotional disturbances in patients with acute myocardial infarction: a controlled study.
Topics: Acute Disease; Adult; Affective Symptoms; Aged; Anthracenes; Antidepressive Agents; Anxiety; Clinical Trials as Topic; Depression; Diazepam; Drug Evaluation; Humans; Male; Maprotiline; Middle Aged; Myocardial Infarction; Psychiatric Status Rating Scales; Surveys and Questionnaires | 1976 |
24 other study(ies) available for diazepam and maprotiline
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Epileptiform seizures with maprotiline hydrochloride.
Topics: Adult; Anthracenes; Diazepam; Epilepsy; Female; Humans; Male; Maprotiline; Middle Aged | 1979 |
Acoustic startle induced ultrasonic vocalization in the rat: a novel animal model of anxiety?
Topics: Animals; Anti-Anxiety Agents; Anxiety; Appetite Depressants; Arousal; Carbolines; Diazepam; Disease Models, Animal; Electroshock; Fear; Flunitrazepam; Male; Maprotiline; Pyrimidines; Rats; Rats, Inbred Strains; Reflex, Startle; Ultrasonics; Vocalization, Animal | 1991 |
Oxaprotiline enantiomers stimulate ACTH and corticosterone secretion in the rat.
Topics: Adrenergic alpha-Antagonists; Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Benzylamines; Corticosterone; Dexamethasone; Diazepam; Dose-Response Relationship, Drug; Male; Maprotiline; Metergoline; Naloxone; Piperidines; Pyrimidines; Radioimmunoassay; Rats; Rats, Inbred Strains; Serotonin Antagonists; Stereoisomerism; Sulpiride; Sympathomimetics | 1991 |
[Maprotiline and the heart rate].
Topics: Blood Pressure; Diazepam; Female; Heart Rate; Humans; Male; Maprotiline; Middle Aged | 1990 |
[Analysis of etizolam, triazolam, nitrazepam and maprotiline in autopsy materials by high-performance liquid chromatography and gas chromatography].
Topics: Anthracenes; Chromatography, Gas; Chromatography, High Pressure Liquid; Diazepam; Female; Forensic Medicine; Humans; Male; Maprotiline; Middle Aged; Nitrazepam; Triazolam | 1987 |
Maprotiline hydrochloride associated with a clinical state of catatonic stupor and epileptic encephalogram.
Topics: Anthracenes; Catatonia; Depressive Disorder; Diazepam; Drug Therapy, Combination; Electroencephalography; Epilepsy; Humans; Male; Maprotiline; Middle Aged; Phenytoin; Thiothixene | 1984 |
Alterations in human memory following acute maprotiline, diazepam and codeine administration.
Topics: Anthracenes; Codeine; Diazepam; Humans; Maprotiline; Memory | 1981 |
Stedim 6 and Clearflex, two new multilayer materials for infusion containers. Comparative study of their compatibility with five drugs versus glass flasks and polyvinyl chloride bags.
Topics: Adsorption; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Chlorpromazine; Clodronic Acid; Clorazepate Dipotassium; Diazepam; Glass; Infusion Pumps; Maprotiline; Polyethylenes; Polyvinyl Chloride; Silicates; Structure-Activity Relationship | 1995 |
Interactions between six psychotherapeutic drugs and plastic containers. Influence of plastic material and infusion solutions.
Topics: Chlorpromazine; Clomipramine; Clorazepate Dipotassium; Diazepam; Humans; Infusions, Parenteral; Maprotiline; Polyethylenes; Polyvinyl Chloride; Psychotropic Drugs; Viloxazine | 1993 |
Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose.
Topics: Adult; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Benzodiazepines; Bundle-Branch Block; Diagnosis, Differential; Diazepam; Electrocardiography; Female; Heart Ventricles; Humans; Hypnotics and Sedatives; Long QT Syndrome; Maprotiline; Myocardial Infarction; Nordazepam; Perphenazine; Triazolam | 1997 |
Antipsychotic, antidepressant, anxiolytic, and anticonvulsant drugs induce type II nitric oxide synthase mRNA in rat brain.
Topics: Animals; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Brain; Carbamazepine; Chlorpromazine; Diazepam; Fluvoxamine; Gene Expression; Haloperidol; Isoxazoles; Lithium; Male; Maprotiline; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Zonisamide | 2002 |
TMD chronic pain and masseter silent period in psychiatric patients on antidepressive therapy.
Topics: Adult; Analysis of Variance; Anti-Anxiety Agents; Antidepressive Agents; Case-Control Studies; Chronic Disease; Diazepam; Drug Therapy, Combination; Electromyography; Facial Pain; Female; Humans; Male; Maprotiline; Masseter Muscle; Mental Disorders; Middle Aged; Temporomandibular Joint Disorders | 2008 |